Found: 43
Select item for more details and to access through your institution.
Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 481, n. 6, p. 975, doi. 10.1007/s00428-022-03386-5
- By:
- Publication type:
- Article
Correction to: Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Antifungal Drugs in the Management of Hematological Diseases in a Home Care Program.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Primary MALT lymphoma of the upper lip mucosa: an exceptionally rare localisation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Primary Pulmonary Hodgkin Lymphoma Simulating a Mediastinal Tumour: an Uncommon Occurrence.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Unusual sequence of lymphoid disorders: Follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 7, p. 1073, doi. 10.1080/02841860902829213
- By:
- Publication type:
- Article
Authors' Reply.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program.
- Published in:
- Indian Journal of Palliative Care, 2011, v. 17, n. 1, p. 54, doi. 10.4103/0973-1075.78450
- By:
- Publication type:
- Article
Access to Holiday in Hematological Patients Managed in a Home Care Program: A Single-Center Experience.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1275, doi. 10.1007/s00277-022-04815-w
- By:
- Publication type:
- Article
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1801, doi. 10.3390/jcm11071801
- By:
- Publication type:
- Article
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5027, doi. 10.3390/cancers15205027
- By:
- Publication type:
- Article
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4112, doi. 10.3390/cancers15164112
- By:
- Publication type:
- Article
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 286, doi. 10.1111/ejh.13436
- By:
- Publication type:
- Article
The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6310, doi. 10.1002/cam4.4179
- By:
- Publication type:
- Article
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231190683
- By:
- Publication type:
- Article
Dysgeusia in patients with hematological malignancies: a reminder for hematologist.
- Published in:
- Journal of Oral Pathology & Medicine, 2013, v. 42, n. 4, p. 352, doi. 10.1111/jop.12034
- By:
- Publication type:
- Article
Back to the future: Treatment‐free remission and pregnancy in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 197, doi. 10.1111/ejh.13192
- By:
- Publication type:
- Article
Characterization of Ph-Negative Abnormal Clones Emerging During Imatinib Therapy.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 12, p. 2466, doi. 10.1002/cncr.22699
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra".
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 4, p. 214, doi. 10.1016/j.clml.2023.11.011
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra".
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S153, doi. 10.1016/S2152-2650(21)01245-3
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 401, doi. 10.1002/hon.2851
- By:
- Publication type:
- Article
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 6, p. 523, doi. 10.1002/ajh.22020
- By:
- Publication type:
- Article
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1527, doi. 10.1080/0284186X.2021.1971292
- By:
- Publication type:
- Article
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1520, doi. 10.1080/0284186X.2021.1971291
- By:
- Publication type:
- Article
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0293-y
- By:
- Publication type:
- Article
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
- Published in:
- Acta Haematologica, 2018, v. 140, n. 4, p. 231, doi. 10.1159/000493880
- By:
- Publication type:
- Article
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1704, doi. 10.1002/cncr.34722
- By:
- Publication type:
- Article
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2657, doi. 10.1002/cncr.33541
- By:
- Publication type:
- Article
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt–mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients.
- Published in:
- Cancer Science, 2010, v. 101, n. 4, p. 991, doi. 10.1111/j.1349-7006.2010.01490.x
- By:
- Publication type:
- Article
Severe peripheral arterial disease during nilotinib therapy.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Severe Peripheral Arterial Disease During Nilotinib Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 17, p. 1347, doi. 10.1093/jnci/djr292
- By:
- Publication type:
- Article